Andrew Craig Miller Karuna Therapeutics, Inc. (KRTX) insider trading activity

Andrew Craig Miller is President of R&D of Karuna Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Jun 11, 2021, when has been sold 8,333 shares (Common Stock) at a price of $9.2 per share, resulting in proceeds of $76,664. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Andrew Craig Miller Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 11 2021	BUY Exercise of conversion of derivative security	$76,664 $9.2 p/Share	8,333 Added 13.4%	53,833 Common Stock
Jun 10 2021	SELL Open market or private sale	$1,649,025 $123.68 p/Share	13,333 Reduced 22.66%	45,500 Common Stock
Jun 10 2021	BUY Exercise of conversion of derivative security	$122,664 $9.2 p/Share	13,333 Added 18.48%	58,833 Common Stock
May 10 2021	SELL Open market or private sale	$552,150 $110.43 p/Share	5,000 Reduced 9.9%	45,500 Common Stock
May 10 2021	BUY Exercise of conversion of derivative security	$46,000 $9.2 p/Share	5,000 Added 9.01%	50,500 Common Stock
Apr 12 2021	SELL Open market or private sale	$571,100 $114.22 p/Share	5,000 Reduced 9.9%	45,500 Common Stock
Apr 12 2021	BUY Exercise of conversion of derivative security	$46,000 $9.2 p/Share	5,000 Added 9.01%	50,500 Common Stock
Mar 10 2021	SELL Open market or private sale	$592,400 $118.48 p/Share	5,000 Reduced 9.9%	45,500 Common Stock
Mar 10 2021	BUY Exercise of conversion of derivative security	$46,000 $9.2 p/Share	5,000 Added 9.01%	50,500 Common Stock
Feb 10 2021	SELL Open market or private sale	$570,300 $114.06 p/Share	5,000 Reduced 9.9%	45,500 Common Stock
Feb 10 2021	BUY Exercise of conversion of derivative security	$46,000 $9.2 p/Share	5,000 Added 9.01%	50,500 Common Stock
Jan 11 2021	SELL Open market or private sale	$525,550 $105.11 p/Share	5,000 Reduced 9.9%	45,500 Common Stock
Jan 11 2021	BUY Exercise of conversion of derivative security	$41,200 $8.24 p/Share	5,000 Added 9.63%	46,928 Common Stock
Dec 14 2020	BUY Exercise of conversion of derivative security	$36,500 $2.92 p/Share	12,500 Added 21.55%	45,500 Common Stock
Dec 10 2020	SELL Open market or private sale	$474,100 $94.82 p/Share	5,000 Reduced 9.9%	45,500 Common Stock
Dec 10 2020	BUY Exercise of conversion of derivative security	$41,200 $8.24 p/Share	5,000 Added 9.63%	46,929 Common Stock
Nov 12 2020	SELL Open market or private sale	$833,400 $100.0 p/Share	8,334 Reduced 20.16%	33,000 Common Stock
Nov 12 2020	BUY Exercise of conversion of derivative security	$76,673 $9.2 p/Share	8,334 Added 16.78%	41,334 Common Stock
Nov 11 2020	SELL Open market or private sale	$833,383 $100.01 p/Share	8,333 Reduced 20.16%	33,000 Common Stock
Nov 11 2020	BUY Exercise of conversion of derivative security	$76,664 $9.2 p/Share	8,333 Added 16.78%	41,333 Common Stock
Nov 10 2020	SELL Open market or private sale	$1,383,965 $103.8 p/Share	13,333 Reduced 28.78%	33,000 Common Stock
Nov 10 2020	BUY Exercise of conversion of derivative security	$109,864 $8.24 p/Share	13,333 Added 24.08%	42,047 Common Stock
Oct 12 2020	SELL Open market or private sale	$393,350 $78.67 p/Share	5,000 Reduced 13.16%	33,000 Common Stock
Oct 12 2020	BUY Exercise of conversion of derivative security	$36,350 $7.27 p/Share	5,000 Added 11.63%	38,000 Common Stock

ACM

Andrew Craig Miller

President of R&D

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Karuna Therapeutics, Inc.

Track Activities on KRTX

Account